Stock Analysis on Net

RTX Corp. (NYSE:RTX)

Income Statement 
Quarterly Data

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

RTX Corp., consolidated income statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 3, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Products sales 15,551 14,591 16,039 14,708 14,562 14,303 14,758 8,615 13,411 12,787 13,897 12,756 12,258 11,862 13,096 12,331 12,179 11,664 12,917 11,469 10,768 8,165
Services sales 6,030 5,715 5,584 5,381 5,159 5,002 5,169 4,849 4,904 4,427 4,196 4,195 4,056 3,854 3,948 3,882 3,701 3,587 3,502 3,278 3,293 3,195
Net sales 21,581 20,306 21,623 20,089 19,721 19,305 19,927 13,464 18,315 17,214 18,093 16,951 16,314 15,716 17,044 16,213 15,880 15,251 16,419 14,747 14,061 11,360
Cost of sales, products (12,989) (12,283) (13,591) (12,336) (12,625) (12,216) (12,347) (9,289) (11,089) (10,700) (11,574) (10,493) (10,040) (9,820) (10,828) (10,296) (9,997) (9,974) (11,566) (10,322) (9,620) (6,629)
Cost of sales, services (4,216) (3,907) (3,797) (3,719) (3,516) (3,528) (3,571) (3,461) (3,429) (2,945) (2,952) (2,971) (2,816) (2,740) (2,788) (2,793) (2,658) (2,563) (2,700) (2,682) (2,594) (1,943)
Cost of sales (17,205) (16,190) (17,388) (16,055) (16,141) (15,744) (15,918) (12,750) (14,518) (13,645) (14,526) (13,464) (12,856) (12,560) (13,616) (13,089) (12,655) (12,537) (14,266) (13,004) (12,214) (8,572)
Gross margin 4,376 4,116 4,235 4,034 3,580 3,561 4,009 714 3,797 3,569 3,567 3,487 3,458 3,156 3,428 3,124 3,225 2,714 2,153 1,743 1,847 2,788
Research and development (697) (637) (808) (751) (706) (669) (757) (712) (729) (607) (716) (662) (698) (635) (810) (676) (657) (589) (710) (642) (695) (535)
Selling, general, and administrative (1,573) (1,448) (1,574) (1,389) (1,449) (1,394) (1,375) (1,401) (1,635) (1,398) (1,379) (1,391) (1,424) (1,469) (1,407) (1,229) (1,368) (1,220) (1,351) (1,401) (1,811) (977)
Goodwill impairment (3,183)
Other income (expense), net 40 4 258 134 (896) 372 (30) 3 25 88 29 46 17 28 109 124 82 108 50 734 82 19
Operating profit (loss) 2,146 2,035 2,111 2,028 529 1,870 1,847 (1,396) 1,458 1,652 1,501 1,480 1,353 1,080 1,320 1,343 1,282 1,013 142 434 (3,760) 1,295
Non-service pension income 351 366 384 374 374 386 446 443 447 444 467 468 474 480 472 491 490 491 244 253 237 168
Debt extinguishment costs (649)
Interest expense, net (457) (443) (486) (496) (475) (405) (488) (369) (333) (315) (318) (311) (329) (318) (276) (358) (342) (346) (349) (350) (335) (332)
Non-operating income (expense), net (106) (77) (102) (122) (101) (19) (42) 74 114 129 149 157 145 162 (453) 133 148 145 (105) (97) (98) (164)
Income (loss) from continuing operations before income taxes 2,040 1,958 2,009 1,906 428 1,851 1,805 (1,322) 1,572 1,781 1,650 1,637 1,498 1,242 867 1,476 1,430 1,158 37 337 (3,858) 1,131
Income tax (expense) benefit (315) (333) (449) (371) (253) (108) (332) 389 (213) (300) (182) (242) (160) (116) (96) (3) (342) (345) 178 (152) 38 (639)
Net income (loss) from continuing operations 1,725 1,625 1,560 1,535 175 1,743 1,473 (933) 1,359 1,481 1,468 1,395 1,338 1,126 771 1,473 1,088 813 215 185 (3,820) 492
Net income (loss) from discontinued operations (19) 1 (7) (8) (19) (11) 113 9 (478)
Net income (loss) 1,725 1,625 1,560 1,535 175 1,743 1,473 (933) 1,359 1,481 1,468 1,395 1,338 1,107 772 1,466 1,080 794 204 298 (3,811) 14
Noncontrolling interest in subsidiaries’ earnings (68) (90) (78) (63) (64) (34) (47) (51) (32) (55) (46) (8) (34) (23) (86) (73) (48) (41) (69) (34) (24) (97)
Net income (loss) attributable to common shareowners 1,657 1,535 1,482 1,472 111 1,709 1,426 (984) 1,327 1,426 1,422 1,387 1,304 1,084 686 1,393 1,032 753 135 264 (3,835) (83)

Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-03), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


Net Sales Trend
Net sales exhibit a generally upward trend over the periods analyzed, rising from $11,360 million in March 2020 to a peak of $21,623 million in June 2025. There are periods of fluctuation, such as a notable dip to $13,464 million in September 2023, but overall net sales increase steadily, indicating growth in overall revenue generation.
Products and Services Sales
Product sales show variability with a peak of $13,097 million in December 2021 and a low of $8,615 million in September 2023. A significant decline is observed in late 2023 followed by a recovery trend. Services sales steadily increase from $3,195 million in March 2020 to over $6,000 million by June 2025, demonstrating consistent expansion in service offerings or demand.
Cost of Sales and Gross Margin
Cost of sales for products and services increases alongside sales but at a somewhat slower pace, allowing gross margin to generally improve over time. Gross margin fluctuates but ends higher at $4,376 million in December 2025 compared to $2,788 million in March 2020. This reflects improved efficiency or pricing power in the business despite cost pressures.
Operating Profit and Expenses
Operating profit displays volatility with a large negative spike of -$3,760 million in June 2020, likely driven by extraordinary items such as goodwill impairment recorded in the same period. Following recovery, operating profit remains positive and grows to approximately $2,146 million by December 2025. Research and development expenses remain relatively stable across periods, indicating consistent investment. Selling, general, and administrative expenses show fluctuations but no clear upward or downward trend, suggesting steady control over these costs.
Goodwill Impairment and Exceptional Items
A significant goodwill impairment charge appears only in June 2020, contributing to the substantial operating loss and negative net income in that quarter. Debt extinguishment costs of -$649 million are noted in December 2020 but do not recur. These one-time charges impact profitability in respective quarters and contribute to volatility in reported earnings.
Income and Taxation
Income before taxes recovers following 2020 losses and generally trends upward, reaching over $2,000 million by mid-2025. Income tax expense varies, sometimes showing a tax benefit, especially in quarters with losses. Net income from continuing operations follows a similar recovery and growth pattern, showing resilience and improved profitability over time despite some quarters with negative earnings.
Net Income and Shareholder Earnings
Net income aligns closely with continuing operations net income and fluctuates similarly. Notable is a sharp loss in June 2020 and in September 2023. However, the later periods show increased net income reaching peak values toward mid-2025. Net income attributable to common shareowners follows this trend but with some divergence due to noncontrolling interests, which vary but tend to be negative, reducing the earnings available to common shareholders.
Non-Operating Items
Non-service pension income remains steady, contributing positively. Interest expense fluctuates but tends to increase over time, indicating rising financing costs. Non-operating income shows variability with occasional positive spikes offset by substantial negative values, such as -$896 million in September 2023, affecting overall profitability.
Overall Financial Health Insights
The analyzed data indicates a company recovering from severe financial challenges in 2020, notably due to goodwill impairment and extraordinary losses. Subsequent quarters show consistent growth in sales and improving profitability, although some volatility remains in expenses and non-operating results. Cost management appears effective in sustaining gross margin improvements. Increasing service sales contribution suggests strategic diversification. Management’s emphasis on research and development and controlled selling expenses supports sustainable growth. Rising interest expenses and occasional large non-operating losses warrant monitoring for potential impact on future profitability.